We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aortech International Plc | LSE:AOR | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 126.50 | 123.00 | 130.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
05/1/2018 12:59 | just recovering losses over last few days. swings on minimal volume. | donalc | |
05/1/2018 12:58 | Very little available at 44 if someone wants to clear them :) | bean02 | |
05/1/2018 12:56 | Up 15% is this correct. | blueball | |
05/1/2018 12:23 | Agreed Riskybisky. It is worth taking the time to re-read the RNS history of the past 5 years to appreciate the pain that the company went through from the time the ex-CEO saga began. It gives a great feel for the potential of this company and its products and IP. We are not talking blue sky here. These are here and now market leading technologies with enormous market potential. | bones | |
05/1/2018 12:14 | The RNS of 11 December 2017 really is worth a re-read, it certainly prompted me to top up. The risks seem so low here and the upside is I would think potentially massive. This sentence from the RNS alone says a lot, though there's much more in the RNS: "The value added to licensees is not only greater than licence fees payable, but the value of the licence fees to our customers is significantly more than the market capitalisation of AorTech" | riskybisky | |
05/1/2018 11:59 | A few shares I'm currently in have similar pennants on the charts just waiting to breakout - AOR, MYN, VAL | spawny100 | |
05/1/2018 11:58 | Up another 4p today. | blueball | |
05/1/2018 11:58 | Just bought at 42p but like getting blood out of a stone !!!! | parsons4 | |
05/1/2018 11:20 | But can sell loads at 40 | mikeh30 | |
05/1/2018 11:12 | cant buy online at moment. | donalc | |
05/1/2018 09:53 | Stig Good post. AorTech was 20 years ahead of its time first time round with the polymer heart valve. At that point the major valve companies were getting rich from the switch from mechanical to animal tissue valves. Those same companies are now fretting about sourcing non contaminated animal tissue, finding skilled operatives to make the valves (it is really boring work!) and the fact that they are no longer making any money out of animal tissue valves. The market is now ready for a polymer valve BUT more importantly, the majors need it now rather than license it to bury it. | landy90 | |
05/1/2018 09:08 | TS thanks for that. | parsons4 | |
04/1/2018 23:41 | Parsons. I have a old university friend who is a cardiac specialist so knows this area intimately. He has purchased shares following our discussion. What I think many do not understand is that this is a wide open massive long term growth market. Previous 'failures' count for nothing if you are still in their pitching to be the 'Holy Grail' solution that cardiac patients and cardiac specialists are crying out for. My sense is that AOR is potentially 10-100x undervalued | the stigologist | |
04/1/2018 19:53 | I bought even more today they are now one of my main holdings I love the story and having gone through the last 5 years RNSs I think that the new team have done a good job and SHOULD create a much more profitable entity. A market cap of £2m just seems far too low. I would like to understand a bit more about the new "heart valve" product if anybody can help as I have a friend who went into hospital today to have a valve replacement !! | parsons4 | |
03/1/2018 11:19 | Quite a large sell there. Whoever they are they must be mad. | investordave | |
03/1/2018 11:04 | They don't have any stock so try to shake out weak holders by lowering bid whilst maintaining ask | the stigologist | |
03/1/2018 10:13 | What's the point of that spread | davisc5 | |
02/1/2018 11:10 | Stig, Im sure you were to provide some info unless I missed it.. | mustau | |
02/1/2018 11:10 | Not expecting much this week . | blueball | |
31/12/2017 14:09 | Like the sound of 'exponential growth' from Biomerics | the stigologist | |
30/12/2017 10:21 | the tree has been shook. thats all they could get. Lok forward to the new year, volatility will be the name of the game. | donalc | |
29/12/2017 22:13 | Also bought some more today I could not buy in large quantities though !! | parsons4 | |
29/12/2017 10:48 | Suprised this is still at these level, I fully expected well over 50p. Ho Hum, opportunity to add. Hopefully they will fully exploit their IP in 18. Atb for 18 all. | mustau |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions